VOLITIONRX LTD — Director's Dealing 2021

Feb 2, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2021-02-01

Reporting Person: Forterre Gael (Chief Commercial Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	48500	Direct
Common Stock	5000	Indirect
Common Stock	32500	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrant (Right to Buy)	$3.95	2027-01-01	Common Stock (125000)		Direct

Footnotes

F1: These shares of Common Stock are managed by Armori Capital Management, LLC. Mr. Forterre is the managing director and sole shareholder of Armori Capital and has voting and dispositive control over the shares held by Armori Capital. Mr. Forterre disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein

F2: On January 1, 2021, the Mr. Forterre was granted a warrant to purchase up to 125,000 shares of Common Stock of the issuer at an exercise price of $3.95 per share. The warrant will vest in full twelve months from the date of grant (subject to continuous employment through such date).